Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries

• Status: Completed
• Trial end date: 2014-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The use of prophylaxis for venous thromboembolism (VTE) remains grossly underused for women who undergo gynecologic surgery for benign conditions world wide and especially in developing countries including our region. Having a research in our locality for the first time might raise awareness of the importance of VTE prophylaxis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hawler Medical University
• Treatments: Bemiparin; Heparin, Low-Molecular-Weight

Criteria

Inclusion Criteria:

• female undergoing Benign gynecological surgeries.

• Having moderate,high and very high risk factors for venous thromboembolism.

• No contraindications for the use of Heparin.

Exclusion Criteria:

• Having mild risk factors for thromboembolism.

• Active vaginal bleeding.

• Thrombocytopaenia.

• any patient who is already on anticoagulant.

• Sever renal or Liver diseases.